Onesource Specialty Pharma Limited — Others, 30-06-2025: Shareholders meeting

OneSource Specialty Pharma Limited has announced a board meeting to seek shareholder approval via postal ballot for two key proposals: the appointment of Mr. Colin Michael Bond as an Independent Director for five years, and revision of Managing Director Mr. Neeraj Sharma’s remuneration. Mr. Bond brings extensive CFO experience across global markets and will also chair the Audit Committee. Mr. Sharma’s revised pay is INR 65.87 million per annum, effective April 1, 2025, reflecting his leadership in driving 30% revenue growth and doubling EBITDA in FY25 amid strategic mergers and operational improvements. Shareholders can vote electronically until July 30.